Dictionary

allow_url_fopen is ENABLED Dictionary Search

infliximab

Synonyms

Noun

1. Remicade

2. anti-TNF compound

Usage
Subcutaneous Infliximab for CD by Location - Docwire News
Subcutaneous Infliximab Recaptures Disease Control After Treatment Interruption in IBD - HCPLive
Pharmacokinetic Model Selection for Personalized Infliximab Dosing in IBD - Wiley
‘Pleasantly surprised’: Subcutaneous infliximab effective, regardless of Crohn’s location - Healio
Infliximab as ultima ratio in a case of refractory non-Crohn’s disease complex fistula system: case report and mini-review of the literature - Frontiers
Subcutaneous Infliximab Shows Promise for Durable, Patient-Centered IBD Care - BioPharm International
Ileocaecal resection versus infliximab for ileal Crohn's disease: retrospective 10-year follow-up of the LIR!C trial - The Lancet
Melkersson-Rosenthal Syndrome: A Case Treated With Infliximab - Cureus
Additive effects of fecal microbiota transplantation and infliximab on gut microbiome and metabolome in refractory inflammatory bowel disease patients - ASM Journals
Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA® (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal - PR Newswire
The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial Insurance - The American Journal of Managed Care® (AJMC®)
Danish Registry Analysis Finds Consistent Safety After Switching to Infliximab Biosimilar GP1111 - Center for Biosimilars
Infliximab and Adalimumab Biosimilars Maintain Comparable Safety, Efficacy, Immunogenicity in IBD - Pharmacy Times
Early Colectomy After Infliximab in Ulcerative Colitis Linked to C. difficile Infection - Docwire News
Severe cerebellitis as a manifestation of infliximab-associated overlap of neurosarcoidosis and myelin oligodendrocyte glycoprotein antibody-associated disease – case report - Frontiers
Fulminant Tetraplegia in a Patient on Infliximab: A Case of Masked Cervical Spinal Epidural Abscess Presenting With Dysphagia - Cureus
Subcutaneous Infliximab May Improve Convenience, Adherence, and Sustained Remission in IBD Care - BioPharm International
Infliximab for intravenous immunoglobulin-resistant Kawasaki disease complicated with cholestatic hepatitis: a case report and discussion on coronary artery aneurysm prevention - Frontiers
Secondary Hemophagocytic Lymphohistiocytosis in a Patient With Crohn’s Disease Receiving Infliximab: A Diagnostic Challenge - Cureus
Bilateral Renal Artery Thrombosis in a Patient With Behçet’s Disease Managed With Infliximab Infusions - Cureus
Implications of the First Liquid IV Infliximab Biosimilar - BioPharm International
Top 20 Companies in Global Infliximab Biosimilar Market: Strategic Overview and Future Trends (2026–2035) - Spherical Insights
Infliximab, Upadacitinib Offer Rapid Relief in Ulcerative Colitis - Medscape
Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patients - Frontiers
Celltrion Launches IV Formulation of Biosimilar Infliximab in Europe - Pearce IP
Study Shows Infliximab Biosimilar is Safe in Patients Undergoing RA Treatment - Pharmacy Times
C difficile and CRP-to-Albumin Ratio Predict Colectomy in ASUC After Infliximab - Infectious Disease Advisor
Celltrion Secures First Approval of Infliximab IV Liquid Formulation - Pearce IP
Accelerated infliximab induction reduces long-term odds of colectomy in ulcerative colitis - Healio
Eruptive cherry angiomas induced by infliximab in a patient with Crohn's disease - Elsevier
Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW) - PR Newswire
Celltrion launches liquid formulation of Remsima IV in Europe to strengthen infliximab market leadership - koreabiomed.com
Fulminant Tuberculous Pericarditis Presenting as Cardiac Tamponade in an Infliximab-Treated Patient - Cureus
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday - BioSpace
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab - Business Wire
4 Types of Biologics Used for Ulcerative Colitis - Verywell Health
Comparison of endoscopic healing and durability between combination therapy with infliximab and azathioprine versus infliximab monotherapy in pediatric Crohn’s disease - Nature
VIDEO: ‘High index of suspicion,’ liver biopsy help diagnose rare infliximab complication - Healio
Successful Treatment of Pediatric Neurosarcoidosis With Corticosteroids, Infliximab, and Methotrexate - ScienceDirect.com
Case Report: Facial Malassezia folliculitis following infliximab treatment in Crohn’s disease - Frontiers
Corticosteroid Premedication for Infliximab Remains Unnecessarily Common - The American Journal of Managed Care® (AJMC®)
Infliximab treatment for autoimmune hepatitis - Clínica FEHV
Australian Patients With IBD Switched to Biosimilar Infliximab Maintain Long-Term Persistence - Center for Biosimilars
Risk of Autoimmune Hepatitis Among Patients with Inflammatory Bowel Disease Treated with Infliximab: A Retrospective Cohort Study Using a National Database - Springer Nature Link
Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease - NEJM Evidence
Pfizer’s IV Infliximab Biosimilar Approved in NZ - Pearce IP
FDA Approves First Subcutaneous Infliximab Product - Center for Biosimilars
Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series - Wiley Online Library
Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome - NEJM Evidence
Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis - Frontiers
Meta‐Analysis: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease - Wiley Online Library
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease - The New England Journal of Medicine
Infliximab treatment in pathology-confirmed neurosarcoidosis - Neurology® Journals
Effectiveness of switching to subcutaneous infliximab in inflammatory bowel disease patients with inadequate biochemical response during intravenous administration - Nature
Case Studies Highlight Link Between Crohn’s Disease Treatment and IgAN - Docwire News
FDA Approves First Subcutaneous Infliximab for Maintenance Therapy in UC and Crohn Disease - HCPLive
Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis - Nature
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial - The Lancet
Subcutaneous Infliximab Therapy Efficacious for Inflammatory Bowel Disease - Gastroenterology Advisor
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials - The Lancet
Association of the TNFRSF1B -rs1061622 variant with nonresponse to infliximab in ulcerative colitis - Nature
Celltrion’s Remsima cements status as S.Korea’s blockbuster global medicine - KED Global
Zymfentra, a Subcutaneous Formulation of Infliximab, Approved for IBD - Medical Professionals Reference
FDA Approves Amgen's AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab) - Amgen
Biosimilars of infliximab - Generics and Biosimilars Initiative
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome - Nature
Infliximab concentrations in two non-switching cohorts of patients with inflammatory bowel disease: originator vs. biosimilar | Scientific Reports - Nature
How Long Does Remicade Take to Work for Ulcerative Colitis? - HealthCentral
Infliximab Cost - News-Medical
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease - The New England Journal of Medicine
Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease - Frontiers
Timing of Infliximab Infusion Prior to Surgery and Post-Operative Infections - Rheumatology Advisor
Weight Gain on Infliximab Tied to Sex, Crohn Disease, and Disease Severity - Gastroenterology Advisor
A Case of Drug-Induced Lupus in Crohn’s Disease During Infliximab Therapy - Cureus
Monocytes from infliximab-resistant patients with Crohn’s disease exhibit a disordered cytokine profile - Nature
Remsima from Celltrion Inc - infliximab biosimilar reshapes IBD therapy costs - Ad-hoc-news.de
Celltrion Wins FDA Approval for First Subcutaneous Version of IBD Drug Infliximab - BioSpace
Effectiveness of tacrolimus therapy in refractory ulcerative colitis compared to infliximab with propensity score matching - Nature
Preventing Crohn's Disease Recurrence Regueiro Report Infliximab - Gastroenterology & Endoscopy News
Subcutaneous Infliximab advanced therapy biologics safety IBD - Gastroenterology & Endoscopy News
Vedolizumab Beats Infliximab as Second-Line Therapy for Ulcerative Colitis - Medscape
Patients Report Satisfaction Switching From Infliximab to Biosimilars - Gastroenterology & Endoscopy News
Efficacy and Safety of Infliximab Versus Adalimumab in Adult Subjects With Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis - Cureus
European Commission Grants Approval of Remsima IV Liquid Formulation, Worlds First Liquid Formulation of IV Infliximab - MEDI:GATE NEWS
Subcutaneous Infliximab or Vedolizumab maintenance IBD Upadacitinib Crohn's disease Miguel Regueiro - Gastroenterology & Endoscopy News
Detecting early safety signals of infliximab using machine learning algorithms in the Korea adverse event reporting system - Nature
Celltrion announced on the 19th that its infliximab subcutaneous injection (SC) formulation treatmen.. - 매일경제
No Difference in Pediatric Growth Rates with Infliximab Biosimilar vs Reference Agent - HCPLive
Treating IBD During Pregnancy - Johns Hopkins Medicine
FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union - Biogen
Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report - Frontiers
Posters Demonstrate Switching Safety Between Originator, Biosimilar Infliximab in IBD - Center for Biosimilars
Are Live Vaccines Safe for Infants Exposed to Infliximab During Parent’s IBD Treatment? - Gastroenterology Advisor
SC Infliximab Superior to IV Dosage in Patients With Crohn Disease, Ulcerative Colitis - Center for Biosimilars
Initial dose of infliximab 5 mg/kg ‘should be adequate’ in most cases of acute severe UC - Healio
Case Report: Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy - Frontiers
Early Crohn's treatment 'could save NHS millions' - BBC
Infliximab Maintenance Therapy Immunosuppressant - Gastroenterology & Endoscopy News
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome - Nature
ZYMFENTRA™(infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab, now commercially available in the U.S. - PR Newswire
Foreign Language Equivalents
Foreign Language Equivalents of 'infliximab'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
inliximab,   infliximav,   inflixomab,   influximab,   ingliximab,   inflixinab,   infliximmab,   inffliximab,   onfliximab,   inflixximab,   infloximab,   inf;iximab,   ibfliximab,   imfliximab,   nfliximab,   infliimab,   infliximan,   innfliximab,   infliximabb,   ifliximab,   ifnliximab,   inflixiab,   inflixumab,   nifliximab,   infiximab,   inflixiamb,   indliximab,   infliximb,   inlfiximab,   infliximba,   infliiximab,   infilximab,   inflxiimab,   inflicimab,   inflixiimab,   infliximsb,   inflixmab,   unfliximab,   inflixima,   inflximab,   inflizimab,   inflixmiab,   inflliximab,   inflixi,ab,   infliixmab,   iinfliximab,   infkiximab,   infliximaab
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z